- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Women Diagnosed With Cancer in Korea, Republic of
Total 57 results
-
National Cancer Center, KoreaUnknownCancer | Sexuality | Healthy WomenKorea, Republic of
-
Yonsei UniversityCompletedPostemenopusal Women With OsteopeniaKorea, Republic of
-
Alvogen KoreaCompletedPostmenopausal Women With OsteoporosisKorea, Republic of
-
Tehran University of Medical SciencesUnknownWomen With PMSIran, Islamic Republic of
-
Asan Medical CenterRecruitingSubjects With Resectable and Localized Gastric Cancer | Subjects With Resectable Esophageal Cancer or Liver Cancer | Subjects With Resectable Liver CancerKorea, Republic of
-
Asan Medical CenterRecruitingPatients With Suspected or Diagnosed Central Nervous System LymphomaKorea, Republic of
-
Samsung Medical CenterUnknownHemiplegic Cerebral Palsy With Spasticity (Diagnosis)Korea, Republic of
-
Daegu Catholic University Medical CenterCompletedAttention Deficit Hyperactivity Disorder | Psychiatric Diagnosis | Diagnosis, PsychiatricKorea, Republic of
-
Samsung Medical CenterEDGC Inc.CompletedLung Cancer | Diagnoses DiseaseKorea, Republic of
-
Korea University Guro HospitalRecruitingLung Cancer | DiagnosisKorea, Republic of
-
Yonsei UniversityUnknownOpen Gastrectomy With Gastric CancerKorea, Republic of
-
Elevar TherapeuticsBukwang Pharmaceutical, Co., Ltd.CompletedCancer Patients With Solid TumorsKorea, Republic of, United States
-
Seoul National University HospitalActive, not recruitingDiagnoses DiseaseKorea, Republic of
-
Asan Medical CenterCompletedStage IV Gastric Cancer With MetastasisKorea, Republic of
-
Kyungpook National University HospitalNational Cancer Center, Korea; Chonnam National University Hospital; Daegu Catholic... and other collaboratorsUnknownAdvanced Gastric Cancer With Serosal InvasionKorea, Republic of
-
Seoul National University HospitalCompletedBile Duct Cancer | Ampulla of Vater Cancer | Periampullary Cancers With Obstructive Jaundice | Pancreas Head CancerKorea, Republic of
-
Yonsei UniversityNot yet recruitingResectable Pancreatic Cancer With Biliary ObstructionKorea, Republic of
-
Yonsei UniversityRecruitingPostoperative Morbidity and Mortality After Gastrectomy for Gastric Cancer: Prospective Cohort StudyPatients Who Underwent Gastrectomy With Lymph Node Dissection for Gastric CancerKorea, Republic of
-
Samsung Medical CenterCompleted
-
Seoul National University Bundang HospitalActive, not recruitingLung Cancer | Lung Cancer (Diagnosis)Korea, Republic of
-
Ho-Seong HanSeoul National University Bundang HospitalRecruitingPancreas Cancer | DiagnosisKorea, Republic of
-
Yonsei UniversityCompletedGastric Cancer With Peritoneal Metastasis (PCI<12)Korea, Republic of
-
Samsung Medical CenterCompletedHER2-positive Gastric Cancer Patients With Liver MetastasisKorea, Republic of
-
Yonsei UniversityUnknownThe Patients With Gastric Cancer Who Are Scheduled to Receive Laparoscopy Assisted GastrectomyKorea, Republic of
-
Samsung Medical CenterActive, not recruitingNon-Small Cell Lung Cancer With EGFR T790M Mutation | With Brain and/or Leptomeningeal Metastasis | Failed Tyrosine Kinase InhibitorsKorea, Republic of
-
Gachon University Gil Medical CenterCompletedColorectal Cancer With Liver MetastasisKorea, Republic of
-
Yonsei UniversityWithdrawnGastric Cancer With Metabolic Syndrome or Metabolic DiseaseKorea, Republic of
-
Yonsei UniversityRecruitingTriple Negative Breast Cancer | Metastatic Breast Cancer With HER2 PositiveKorea, Republic of
-
Samsung Medical CenterTerminatedPhase I: To Determine the Maximum Tolerated Dose (MTD) | Phase II: To Assess the Pathologic CR Rate and Feasibility Following Neoadjuvant Chemoradiation Therapy With S1/OxaliplatinKorea, Republic of
-
Samsung Medical CenterUnknownCorrection of Cancer-related Coagulopathy With Novel Oral Anticoagulant (Edoxaban)Korea, Republic of
-
Yonsei UniversityTakedaRecruitingPlatinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP InhibitorKorea, Republic of
-
Georgetown UniversityNational Cancer Institute (NCI); American Cancer Society, Inc.; Susan G. Komen...CompletedStudy Chinese Women Who Have Not Adhered to American Cancer Society Mammography Screening GuidelineUnited States
-
SandozHexal AGCompletedPostmenopausal Women With OsteoporosisUnited States, Bulgaria, Czechia, Japan, Poland, Spain
-
AmgenCompletedPostmenopausal Women With OsteoporosisUnited States, Canada, Denmark, France, Germany, Italy, Belgium, Colombia, Czechia, Mexico, Poland, Russian Federation, Netherlands, Hungary, Peru, Turkey, Taiwan, Spain, Hong Kong, Austria, Slovakia, United Kingdom, South Africa, Aus... and more
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
Novartis PharmaceuticalsTerminatedPatient Diagnosed With OCD and Resistant to SSRI Treatment | Failed SSRI Over 12 Weeks at Appropriate DosesGermany, Switzerland, Bulgaria, United States, Czech Republic
-
German Breast GroupPfizer; AGO Study Group; Breast International Group; NSABP Foundation IncCompletedBreast Cancer | Hormonreceptor Positive | Her2-normal | Postneoadjuvant Treatment With CDK 4/6 Inhibitor | CPS-EG ScoreUnited States, Australia, Austria, Canada, France, Germany, Ireland, Japan, Korea, Republic of, Spain, United Kingdom
-
Kura Oncology, Inc.CompletedThyroid Cancer | Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) | HRAS Mutant Tumor | Other Squamous Cell Carcinoma (SCC) With HRAS Mutant TumorSpain, United States, Korea, Republic of, France, Belgium, Germany, Greece, Italy, Netherlands, United Kingdom
-
PfizerCompletedNon-small Cell Lung Cancer With EGFR-Activating MutationsItaly, Poland, China, Hong Kong, Spain, Korea, Republic of, Japan
-
Taiho Oncology, Inc.CompletedBreast Cancer | Gastric Cancer | Cholangiocarcinoma | Urothelial Cancer | Primary CNS Tumors | Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR TumorsFrance, United States, Korea, Republic of, United Kingdom, Japan, Hong Kong, Australia, Taiwan, Italy, Canada, Germany, Netherlands, Spain
-
Criterium, Inc.EMD Serono Research & Development Institute, Inc.TerminatedAdvanced Non-Small Cell Lung Cancer With MET MutationsUnited States
-
Medicenna Therapeutics, Inc.Merck Sharp & Dohme LLCRecruitingClear Cell Renal Cell Carcinoma | Cervical Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Solid Tumor | Squamous Cell Carcinoma of Head and Neck | Bladder Cancer | Skin Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Primary Peritoneal Cancer | Endometrial Carcinoma and other conditionsUnited States, Australia, Korea, Republic of, Canada
-
AmgenCompletedBone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast Cancer | Bone Metastases in Subjects With Advanced Cancer or Multiple MyelomaUnited Kingdom, Czech Republic
-
Galena Biopharma, Inc.CompletedBreast Cancer With Low to Intermediate HER2 ExpressionUnited States, United Kingdom, France, Israel, Germany, Canada, Russian Federation, Romania, Bulgaria, Czech Republic, Hungary, Poland, Ukraine
-
Astellas Pharma IncCompletedNon-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based ChemotherapyUnited Kingdom, United States, Brazil, Canada, Germany, Korea, Republic of, Poland, Romania, Russian Federation
-
PrecirixTerminatedAdvanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2 Standard of Care TreatmentUnited States, Canada
-
Daiichi SankyoDaiichi Sankyo Co., Ltd.Active, not recruitingNon-Small Cell Lung Cancer Metastatic | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorUnited States, Spain, Korea, Republic of, France, United Kingdom, Taiwan, Australia, Japan, China, Netherlands, Italy, Germany, Austria, Belgium, Bulgaria, Singapore
-
Taiho Oncology, Inc.RecruitingAdvanced or Metastatic NSCLS With Exon 20 Insertion MutationUnited States, Spain, Canada, Italy, Israel, Japan, United Kingdom, Korea, Republic of, Germany, France, Turkey, Belgium, Netherlands, Philippines, Poland, Singapore